These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 7247498)

  • 41. [Detection of HBsAg and the related antibody (HBsAb) with the radioimmunological method. Behavior of the HBeAg-HBcAb system in HBsAg-positive patients].
    Ortona L; Pizzigallo E; Federico G; Camilli G
    Arch Sci Med (Torino); 1979; 136(4):509-22. PubMed ID: 550751
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [E antigen (HBeAG) and surface antigen (HBsAg) in bladder schistosomiasis].
    Nuti M; Abdullhai SE; Thamer G
    Parassitologia; 1978 Dec; 20(1-3):153-9. PubMed ID: 553266
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antigens of hepatitis B virus: failure to detect HBeAg on the surfaces of HBsAg forms.
    Gerin JL; Wai-Kuo Shih J; McAuliffe VJ; Purcell RH
    J Gen Virol; 1978 Mar; 38(3):561-6. PubMed ID: 75946
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Detection of hepatitis Be antigen with an enzyme immunoassay (author's transl)].
    Lange W; Masihi KN
    Zentralbl Bakteriol A; 1980 Aug; 247(3):296-302. PubMed ID: 6999797
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The detection of alpha-fetoprotein in HBs Ag and HBe Ag carriers.
    Panoyotopoulos S; Yiannacopoulos T; Margari-Papanicolaou P; Christou A
    Allergol Immunopathol (Madr); 1982; 10(1):1-4. PubMed ID: 6177229
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Comparative study of the "e" system (HBeAG/anti-HBeAg) and core antibodies in aggressive chronic hepatitis and liver cirrhosis].
    Marinucci G; Muglia M; Di Giacomo C; Petrucci L; Mancini R; Costa F; Bachetoni A
    Quad Sclavo Diagn; 1981 Mar; 17(1):81-5. PubMed ID: 7313073
    [No Abstract]   [Full Text] [Related]  

  • 47. Relationship between carriage of HBeAg and HBsAg.
    Hyland CA; Shanley BC
    Lancet; 1983 Nov; 2(8359):1140-1. PubMed ID: 6138669
    [No Abstract]   [Full Text] [Related]  

  • 48. Radioimmunoassay for the detection of HBeAg and anti-HBe.
    Zanetti AR; Ferroni P; Bonino F; Recchia S; Aricò S; Palla M; Caspani B
    Boll Ist Sieroter Milan; 1979 Jan; 57(6):811-5. PubMed ID: 95390
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Albumin receptors on HBsAG particles and subsequent sero-conversion designate HBeAG-positive patients among chronic active liver disease patients.
    Tsuji T
    Acta Med Okayama; 1984 Feb; 38(1):89-92. PubMed ID: 6322527
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunosuppressive treatment of HBsAg-positive chronic liver disease: significance of HBeAg.
    Tage-Jensen U; Aldershvile J; Schlichting P
    Hepatology; 1985; 5(1):47-9. PubMed ID: 3881331
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chronic persistent hepatitis: serological classification and meaning of the hepatitis B e system.
    Aldershvile J; Dietrichson O; Skinhøj P; Kryger P; Mathiesen LR; Christoffersen P; Nielsen JO
    Hepatology; 1982; 2(2):243-6. PubMed ID: 7068117
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Physiopathology of the chronicity process. The AgHBe-AcHBe antigenic system in chronic hepatitis and therapeutic immunodepression].
    Nicolaescu T; Boros I; Stoiculescu P; Gheorghe N; Bittman E; Udrescu E; Bordeianu A
    Physiologie; 1981; 18(1):47-50. PubMed ID: 6794051
    [No Abstract]   [Full Text] [Related]  

  • 53. e Antigen in hepatitis B virus infected dialysis patients: assessment of its prognostic value.
    Werner BG; Blumberg BS
    Ann Intern Med; 1978 Sep; 89(3):310-4. PubMed ID: 686540
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Specificity of radioimmunoassay for hepatitis B e antigen.
    Nath N; Fang CT; Kline W; Bowman RJ
    JAMA; 1982 Mar; 247(10):1404. PubMed ID: 7057521
    [No Abstract]   [Full Text] [Related]  

  • 55. [Studies of hepatitis markers in hemodialysis patients in Taiwan].
    Lin HH; Chu CM; Kao SL; Liaw YF
    Taiwan Yi Xue Hui Za Zhi; 1986 Jul; 85(7):687-93. PubMed ID: 3467012
    [No Abstract]   [Full Text] [Related]  

  • 56. Persistence of hepatitis B virus antigens in dried blood.
    Zachoval R; Frösner G; Deinhardt F; Höss D
    Lancet; 1981 Apr; 1(8223):778. PubMed ID: 6110976
    [No Abstract]   [Full Text] [Related]  

  • 57. Hepatitis B virus: a possible cause of serositis in hemodialysis patients.
    Dave MB; Choi YJ; Cohen BD
    Nephron; 1983; 33(3):186-8. PubMed ID: 6843747
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hepatitis B antigen-associated periarteritis nodosa in patients undergoing long-term hemodialysis.
    Drüeke T; Barbanel C; Jungers P; Digeon M; Poisson M; Brivet F; Trecan G; Feldmann G; Crosnier J; Bach JF
    Am J Med; 1980 Jan; 68(1):86-90. PubMed ID: 6101298
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hepatitis B surface antigen in urine of hemodialysis patients.
    Hourani MR; Mayor GH; Greenbaum DS; Hugget DO; Patterson MJ
    Kidney Int; 1978 Apr; 13(4):324-8. PubMed ID: 651131
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hepatitis B infection in patients with end stage renal disease: some characteristics and consequences.
    Walker WG; Hillis WD; Hillis A
    Trans Am Clin Climatol Assoc; 1981; 92():142-51. PubMed ID: 7025423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.